Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: A meta-analysis

Sexually Transmitted Infections

Volumn 81, Issue 3, 2005, Pages 207-212

  Ogilvie, Gina S ^a,b   Patrick, D M ^b   Schulzer, M ^b,c   Sellors, J W ^d   Petric, M ^b   Chambers, K ^b,c   White, R ^b   FitzGerald, J M ^b,c  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d Prog Appropriate Technol Hlth   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACRON; VIRUS DNA;

AREA UNDER THE CURVE; CLINICAL TRIAL; COCHRANE LIBRARY; COLPOSCOPY; DIAGNOSTIC ACCURACY; EMBASE; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; TAMPON; UTERINE CERVIX CARCINOMA IN SITU; VAGINA SMEAR; VIRUS DETECTION; WART VIRUS;

AREA UNDER CURVE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; SELF CARE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VAGINA; VAGINAL SMEARS;

EID: 20644434606     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2004.011858     Document Type: Review

References (44)

1. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. (Comment) CMAJ 2001;164:1017-25.
2. Stoler MH, Schiffman M. Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. (Comment) JAMA 2001;285:1500-5.
3. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. (Comment) Am J Epidemiol 1995;141:680-9.
4. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicoloau test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Mod 2000;132:810-19.
5. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA 1994;272:530-4.
6. Stuart GC, McGregor SE, Duggan MA, et al. Review of the screening history of Alberta women with invasive cervical cancer. (Comment) CMAJ 1997;157:513-19.
7. British Columbia Cancer Agency. Vancouver, BC: Annual Report, Cervical Cancer Screening Program, 2001.
8. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. (Comment) J Pathol 1999;189:12-19.
9. American College of Obstetricians and Gynecologists. Cervical Cytology Screening. ACOG Practice Bulletin No 45. Obstet Gynecol 2003;102:417-27.
10. Wright TC Jr, Cox JT, Massad LS, et al. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. (Comment) (Review) (89 refs) JAMA 2002;287:2120-9.
11. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
12. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000;9:945-51.
13. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monographs, No 31. Oxford: Oxford University Press, 2003:89-96.
14. Farley M, Golding JM, Minkoff JR. Is a history of trauma associated with a reduced likelihood of cervical cancer screening? J Fam Pract 2002;51:827-31.
15. Hislop TG, Deschamps M, Teh C, et al. Facilitators and barriers to cervical cancer screening among Chinese Canadian women. Revue Canadienne de Sante Publique. Can J Public Health 2003;94:68-73.
16. Hislop TG, Mumick GC, Yelland L. Invasive cervical cancer among South Asian women in British Columbia. BC Med J 1995;37:697-9.
17. Sellors JW, Lorincz AT, Mahony JB, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000;163:513-18.
18. Hillemanns P, Kimmig R, Huttemann U, et al. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 1999;354:1970.
19. Morrison EA, Goldberg GL, Hagan RJ, et al. Self-administered home cervicovaqinal lavage: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections. Am J Obstet Gynecol 1992;167:104-7.
20. Rompalo AM, Gaydos CA, Shah N, et al. Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis 2001;33:1455-61.
21. Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. (Comment) JAMA 2000;283:81-6.
22. Gravitt PE, Lacey JV Jr, Brinton LA, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001;10:95-100.
23. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. (Comment) J Clin Pathol 2002;55:435-9.
24. Chang CC, Tseng CJ, Liu WW, et al. Clinical evaluation of a new model of self-obtained method for the assessment of genital human papilloma virus infection in an underserved population. Chang Gung Med J 2002;25:664-71.
25. Harper DM, Noll WW, Belloni DR, et al. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed - biologic concordance and women's preferences. Am J Obstet Gynecol 2002;186:365-73.
26. Harper DM, Hildesheim A, Cobb JL, et al. Collection devices for human papillomavirus. J Fam Pract 1999;48:531-5.
27. Lorenzato FR, Singer A, Ho L, et al. Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples. Am J Obstet Gynecol 2002;186:962-8.
28. Fairley CK, Chen S, Tabrizi SN, et al. Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis 1992;165:1103-6.
29. Coutlee F, Hankins C, Lapainte N. Comparison between vaginal tampan and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group. J Med Virol 1997;51:42-7.
30. Oosterhuis WP, Niessen RW, Bossuyt PM. The science of systematic reviewing studies of diagnostic tests. (Review) (40 refs) Clin Chem Lab Med 2000;38:577-88.
31. Vamvakas EC. Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods. (Comment) Arch Pathol Lab Med 1998;122:675-86.
32. Eggers M, Davey Smith G, Altman D. Systematic reviews in health care: meta analysis in context. Oxford: BMJ Books, 2001.
33. Rosner B. Fundamentals of biostatistics. Pacific Grove, CA, 2000.
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
35. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993;12:1293-316.
36. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002;21:1237-56.
37. Flores Y, Shah K, Lazcano E, et al. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study. Salud Publica de Mexico 2002;44:335-44.
38. Belinson J, Qiao YL, Pretorius R, et al. Prevalence of cervical cancer and feasibility of screening in rural China. Int J Gynecol Cancer 1999;9:411-17.
39. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-44.
40. erratum appears in Gynecol Oncol 2002;84:355
41. Goldie SJ, Kuhn L, Denny L, et al. Policy analysis of cervical cancer screening strategies in low resource settings. JAMA 2001;285:3107-15.
42. Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002;11:265-75.
43. Smith K, Harrington K, Wingood G, et al. Self-obtained vaginal swabs for diagnosis of treatable sexually transmitted diseases in adolescent girls. Archives of Pediatric and Adolescent Medicine 2001;155:676-9.
44. Knox J, Tabrizi SN, Miller P, et al. Evaluation of self collected samples in contrast to practitioner-collected samples for detection of chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis 2000;29:647-54.